S1PR1 and systemic lupus erythematosus: We demonstrated that circPTPN22 regulates T-cell activation by sponging miR-4689 to target S1PR1, which might partially contribute to maladjusted T-cell functions in patients with SLE and thus provide a potential intervention target for SLE treatment.